Wagner Zago (United States of America)
Prothena Biosciences ResearchDr. Zago has served as Prothena’s Chief Scientific Officer since 2017. He joined Prothena in 2012 when the company was founded, serving as Vice President, Head of Research and Head of Pharmacology. Dr. Zago was also Principal Scientist at Elan Pharmaceuticals, Inc., and Janssen Alzheimer Immunotherapy.
Poster Author Of 1 e-Poster
P563 - DEVELOPMENT OF C-TERMINAL Α-SYNUCLEIN VACCINE FOR TREATMENT AND PREVENTION OF PARKINSON’S DISEASE AND OTHER SYNUCLEINOPATHIES (ID 156)
Authors
- Robin M. Barbour (United States of America)
- Abderrahman Elmaarouf (United States of America)
- Andriani Ioannou (United States of America)
- LeeAnn Louie (United States of America)
- Stephen Tam (United States of America)
- Clara Tourino (United States of America)
- Brian Campbell (United States of America)
- Gene G. Kinney (United States of America)
- Wagner Zago (United States of America)
- Michael Holden (United States of America)